Malpuech facial clefting syndrome
Malpuech facial clefting syndrome is a rare genetic disorder characterized by specific facial features, growth retardation, intellectual disability, and other physical abnormalities. The syndrome is named after the French pediatrician who first described it in 1983, Michel Malpuech.
Symptoms and Signs[edit | edit source]
The most common symptoms of Malpuech facial clefting syndrome include cleft lip and cleft palate, micrognathia (small lower jaw), microcephaly (small head size), and hypertelorism (widely spaced eyes). Other features may include growth retardation, intellectual disability, hearing loss, and heart defects.
Causes[edit | edit source]
Malpuech facial clefting syndrome is caused by mutations in the COLEC11 or MASP1 genes. These genes are involved in the development of the face and other parts of the body. The syndrome is inherited in an autosomal recessive manner, which means both copies of the gene in each cell have mutations.
Diagnosis[edit | edit source]
Diagnosis of Malpuech facial clefting syndrome is based on the clinical features and confirmed by genetic testing. Genetic counseling is recommended for families who have a child with this syndrome.
Treatment[edit | edit source]
Treatment for Malpuech facial clefting syndrome is symptomatic and supportive. It may include surgery to repair the cleft lip and palate, speech therapy, and educational support for intellectual disability.
Prognosis[edit | edit source]
The prognosis for individuals with Malpuech facial clefting syndrome varies depending on the severity of the symptoms. With appropriate treatment and support, many individuals with this syndrome can lead a normal life.
See also[edit | edit source]
- Cleft lip and palate
- Micrognathia
- Microcephaly
- Hypertelorism
- Growth retardation
- Intellectual disability
- Hearing loss
- Heart defects
- COLEC11
- MASP1
- Autosomal recessive
- Genetic counseling
Malpuech facial clefting syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD